- Home
- CMS vs QTRX Comparison
CMS vs QTRX Comparison
Compare CMS & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMS | QTRX |
|---|---|---|
| Founded | 1987 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.8B | 306.0M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | CMS | QTRX |
|---|---|---|
| Price | $76.59 | $5.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 3 |
| Target Price | ★ $77.69 | $11.33 |
| AVG Volume (30 Days) | ★ 3.3M | 668.6K |
| Earning Date | 02-05-2026 | 03-16-2026 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | ★ 5.85 | N/A |
| EPS | ★ 3.53 | N/A |
| Revenue | ★ $8,539,000,000.00 | $130,203,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.61 | $28.28 |
| P/E Ratio | $21.17 | ★ N/A |
| Revenue Growth | ★ 13.63 | N/A |
| 52 Week Low | $67.71 | $4.05 |
| 52 Week High | $76.45 | $8.77 |
Technical Indicators
Market Signals| Indicator | CMS | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.73 | 39.14 |
| Support Level | $71.70 | $5.53 |
| Resistance Level | $75.61 | $6.38 |
| Average True Range (ATR) | 1.42 | 0.45 |
| MACD | 0.36 | -0.07 |
| Stochastic Oscillator | 86.02 | 24.34 |
Price Performance
Historical ComparisonAbout CMS CMS Energy Corporation
CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.